Skip to main content
Log in

Season of tumour detection influences factors predicting survival of patients with breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The rate of initial detection of breast tumours varies during the year in a seasonal fashion, more tumours being discovered in late spring/early summer than at other times of the year. This phenomenon is particularly pronounced in young women (< 50 years) with progesterone receptor positive tumours. The present study investigates whether season of tumour detection influences the predictive capacity of several recognised prognostic and risk factors in patients with breast cancer. Axillary nodal status, tumour progesterone receptor status, and season of tumour detection significantly influenced survival in both older (> 50 yrs) and younger (< 50 yrs) patients. Parity, lactational history, body mass index, tumour oestrogen receptor status, and patient age also influenced survival, but these effects were significant only in age groups < 50 or > 50 yrs. Season of detection of tumour did not affect the prognostic significance of axillary nodal status. However, the effect of oestrogen receptor status on survival was more significant in patients who detected their tumours in the spring/summer compared with winter (odds ratio 0.52 and 0.73 respectively). Negative progesterone receptor status was associated with significantly poorer survival only in patients with tumours found in the winter. There was a significant survival disadvantage for nulliparous compared with parous women with breast cancer who were ≥ 50 years at diagnosis, and for women who had never lactated compared with those who had lactated, but this disadvantage was restricted to those who found their tumours in the summer. An increased body mass index (≥ 28) was associated with decreased survival, but this was significant only for those detecting tumours in winter. The increased incidence of detection of breast cancer in spring/summer may reflect cyclic influences on tumour growth. Such influences may be hormonal in nature and may underlie the effect of season of tumour detection on the prognostic influence of lactation, parity, body mass index, and oestrogen and progesterone receptor status in patients with breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lee JAH: Seasonal alterations and the natural history of malignant neoplasms. Prog Clin Cancer 3: 96–106, 1967

    PubMed  Google Scholar 

  2. Jacobsen HK, Janerich DT: (Abstract) Seasonal variation in the diagnosis of breast cancer. Proc Am Assoc Cancer Res 18: 93, 1977

    Google Scholar 

  3. Cohen P, Wax Y, Modan B: Seasonality in the occurrence of breast cancer. Cancer Res 43: 892–896, 1983

    PubMed  Google Scholar 

  4. Hartveit F, Thoresen S, Tangen M, Halvorsen JF: Variation in histology and oestrogen receptor content in breast carcinoma related to tumour size and time of presentation. Clin Oncol 9: 233–238, 1983

    PubMed  Google Scholar 

  5. Mason BH, Holdaway IM, Mullins PR, Kay RG, Skinner SJ: Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status. Breast Cancer Res Treat 5: 171–176, 1985

    PubMed  Google Scholar 

  6. Kirkham N, Machin D, Cotton DWK, Pike JM: Seasonality and breast cancer. Europ J Surg Oncol 11: 143–146, 1985

    Google Scholar 

  7. Cohen P: (Abstract) Breast cancer prognosis and detection of the first symptom. Breast Cancer Res Treat 3: 311, 1983

    Google Scholar 

  8. Mason BH, Holdaway IM, Kay RG, Stewart AW, Skinner SJ: Abstract Season of breast cancer detection and disease progression. NZ Med J 101: 268, 1988

    Google Scholar 

  9. Hawkins RA, Roberts MM, Forrest APM: Oestrogen receptors and breast cancer: current status. Br J Surg 67: 153–169, 1980

    PubMed  Google Scholar 

  10. Fagnart OC, Cambiaso CL, Lejeune MD, Noel G, Maisin H, Masson PL: Prognostic value of concentration of pregnancy-specific beta 1-glycoprotein in serum of patients with breast cancer. Int J Cancer 36: 541–544, 1985

    PubMed  Google Scholar 

  11. McGuire WL: Prognostic factors in primary breast cancer. Cancer Surv 5: 527–536, 1986

    PubMed  Google Scholar 

  12. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420–427, 1988

    PubMed  Google Scholar 

  13. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal growth factor status as predictor of early recurrence and death from breast cancer. Lancet 1: 1398–1402, 1987

    PubMed  Google Scholar 

  14. McNee RK, Mason BH, Neave LM, Kay RG: Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand. Breast Cancer Res Treat 9: 145–150, 1987

    PubMed  Google Scholar 

  15. Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D: Body size and survival in premenopausal breast cancer. Br J Cancer 51: 691–697, 1985

    PubMed  Google Scholar 

  16. Dowsett M, McGarrick GE, Harris AL, Coombes RC, Smith IE, Jeffcoate SL: Prognostic significance of serum prolactin levels in advanced breast cancer. Br J Cancer 47: 763–769, 1983

    PubMed  Google Scholar 

  17. Waseda N, Kato Y, Imura H, Kurata M: Prognostic value of oestrogen and prolactin receptor analysis in human breast cancer. Jpn J Cancer Res 76: 517–523, 1985

    PubMed  Google Scholar 

  18. Bonneterre J, Peyrat JP, Beuscart R, Lefebvre J, Demaille A: Prognostic significance of prolactin receptors in human breast cancer. Cancer Res 47: 4724–4728, 1987

    PubMed  Google Scholar 

  19. Adami HO, Malker B, Holmberg L, Persson I, Stone B: The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315: 559–563, 1986

    PubMed  Google Scholar 

  20. H'st H, Lund E: Age as a prognostic factor in breast cancer. Cancer 47: 2217–2221, 1986

    Google Scholar 

  21. Mason BH, Holdaway IM, Skinner SJ, Stewart AW, Kay RG, Neave LM, Anderson J: Association between season of first detection ot breast cancer and disease progression. Breast Cancer Res Treat 9: 227–232, 1987

    PubMed  Google Scholar 

  22. Holdaway IM: Principles of radioreceptor assays. In: Odell WD, Franchimont P (eds) Principles of Radioreceptor Assays. Wiley, New York, 1982, pp. 255–265

    Google Scholar 

  23. Cox RD: Regression models and life tables (with discussion). J Roy Stat Soc (B) 34: 182–220, 1972

    Google Scholar 

  24. Kennaway DJ, Gilmore TA, Seamark RF: Effect of melatonin feeding on serum prolactin and gonadotrophin levels and the onset of seasonal cyclicity in sheep. Endocrinology 110: 1766–1772, 1982

    PubMed  Google Scholar 

  25. Wright J, Aldhous M, Franey C, English J, Arendt J: The effects of exogenous melatonin on endocrine function in man. Clin Endocrinol 24: 375–382, 1986

    Google Scholar 

  26. Touitou Y, Carayon A, Reinberg A, Bogdan A, Beck H: Differences in the seasonal rhythmicity of plasma prolactin in elderly human subjects: detection in women but not in men. J Endocrinol 96: 65–71, 1983

    PubMed  Google Scholar 

  27. Haus E, Lakatua DJ, Halberg F, Halberg E, Cornelissen G, Sackett LL, Berg HG, Kawasaki T, Ueno M, Uezono K, Matsuoka M, Omae T: Chronobiological studies of plasma prolactin in women in Kyushu, Japan, and Minnesota, USA. J Clin Endocrinol Metab 51: 632–640, 1980

    PubMed  Google Scholar 

  28. Wang DY, De Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Gravelle IH: The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk — A population study of post-menopausal women. Europ J Cancer Clin Oncol 24: 1225–1231, 1988

    PubMed  Google Scholar 

  29. Musey VC, Delwood C, Collins C, Musey PI, Martino-Saltzman MS, Preedy JRK: Long-term effect of a first pregnancy on the secretion of prolactin. New Engl J Med 316: 229–234, 1987

    PubMed  Google Scholar 

  30. Brunning PF, Bonfrer JMG, Verstraeten AA: Prolactin levels after surgery (letter). N Engl J Med 6: 384–385, 1987

    Google Scholar 

  31. Yu MC, Gerkins VR, Henderson BE, Brown JB, Pike MC: Elevated levels of prolactin in nulliparous women. Br J Cancer 43: 826–831, 1981

    PubMed  Google Scholar 

  32. Kwa HG, Bulbrook RD, Cleton F, Verstraeten AA, Hayward JL, Wang DY: An abnormal early evening peak of plasma prolactin in nulliparous and obese post-menopausal women. Int J Cancer 22: 691–693, 1978

    PubMed  Google Scholar 

  33. Meyer F, Brown JB, Morrison AS, MacMahon B: Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Nat Cancer Inst 77: 613–616, 1986

    PubMed  Google Scholar 

  34. Englesman E, Heuson JC, Blonk-Van der Wijst J, Drochmans A, Maass H, Cheix F, Sobrinho LG, Nowakowski H: Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer, an EORTC study. Br Med J 2: 714–715, 1975

    PubMed  Google Scholar 

  35. European Breast Cancer Group: Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancer. Eur J Cancer 8: 155–156, 1972

    Google Scholar 

  36. Holdaway IM, Friesen HG: Hormone binding by human mammary carcinoma. Cancer Res 37: 1946–1951, 1977

    PubMed  Google Scholar 

  37. Di Carlo R, Muccioli G: Prolactin receptor in human mammary carcinoma. Tumori 65: 695–702, 1979

    PubMed  Google Scholar 

  38. Schindler AE, Ebert E, Friedreich E: Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab 5: 627–630, 1972

    Google Scholar 

  39. Onegan WL, Biedrzycki L: (Abstract) Obesity and oestrogen production in breast cancer patients. Cancer Treat Rep 63: 1204, 1979

    Google Scholar 

  40. Shultz TD, Wilcox RB, Spuehler JM, Howie BJ: Dietary and hormonal interrelationships in premenopausal women: evidence for a relationship between dietary nutrients and plasma prolactin levels. Am J Clin Nutr 46: 905–911, 1987

    PubMed  Google Scholar 

  41. Van Staveren WA, Deurenberg P, Burema J, DeGroot LCPGM, Hautvast JGAJ: Seasonal variation in food intake, pattern of physical activity and change in body weight in a group of young adult Dutch women consuming self selected diets. Int J Obesity 10: 133–145, 1986

    Google Scholar 

  42. Gordon DJ, Hyde J, Trost DC, Whaley FS, Hannan PJ, Jacobs DR, Ekelund L: Cyclic seasonal variation in plasma lipid and lipoprotein levels: the Lipid Research Clinic's coronary primary prevention trial placebo group. J Clin Epidemiol 41: 679–689, 1988

    PubMed  Google Scholar 

  43. Hrushesky W, Teslow T, Halberg F, Kiang D, Kennedy BJ: (Abstract) Temporal components of predictable variability along the 1-year scale in oestrogen receptor concentration of primary human breast cancer. ASCO 20 (C-165): 331, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mason, B.H., Holdaway, I.M., Stewart, A.W. et al. Season of tumour detection influences factors predicting survival of patients with breast cancer. Breast Cancer Res Tr 15, 27–37 (1990). https://doi.org/10.1007/BF01811887

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01811887

Key words

Navigation